M-IRBESARTAN

mantra pharma inc🇨🇦 Health Canada

Approval Id: 1d6509c113772f2b
Drug Approval Canada Name: M-IRBESARTAN
Product Name: M-IRBESARTAN
Status: Marketed
Status Date: 2022-07-25
Original Market Date: 2022-07-25
Din: 02524821
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.08
Atc Original: C09CA04 IRBESARTAN
Atc Name: c 09 ca 04
Aig Number: 0131700002
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

IRBESARTAN

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1d6509c113772f2b

Type

Standard